Ovarian cancer represents about 25% of all female genital tract malignancies. However, there are more deaths from this form of cancer each year in the United States than from endometrial cancer and cervical cancer combined. The lifetime risk of developing spontaneous ovarian cancer is about 1.7%. Epithelial ovarian cancer was expected cause 15,520 deaths in 2008. Mean age at diagnosis is 60. There has been a significant improvement in the five year survival rate for patients with ovarian cancer. This is likely a combination of better tumor debulking surgeries and better chemotherapeutic options.
Most patients with this type of ovarian cancer do not have signs or symptoms until disease spreads to the upper abdomen. 70% of patients present with advanced disease. Symptoms for early stage ovarian cancer can include nonspecific pelvic discomfort, urinary frequency and constipation which are caused by an enlarging pelvic mass. With advanced disease, patients experience abdominal pain, bloating, anorexia, nausea and constipation.
The best tumor marker for ovarian cancer is CA 125. Minor elevations in CA 125 can also be seen in endometriosis, benign tumors, fibroids and in pregnant and postpartum women. In addition, moderate elevation of CA 125 can be seen in other adnocarcinoma such as breast and endometrial cancer. The sensitivity of CA 125 is 70% to 80% and the specificity is 98.6% to 99.4%. However, in the average risk population with low prevalence of ovarian cancer, the false positive can be unacceptably high.
The National Cancer Institute recommends screening for ovarian female cancer with known genetic syndromes associated with this disease and for women with strong family history. Routine screening of women without family history of ovarian cancer is not recommended. The known genetic syndromes include hereditary breast and ovarian cancer syndrome associated with BRCA 1, BRCA 2 and Hereditary Nonpolyposis Colorectal Cancer Syndrome (HNPCC). The absolute risk of ovarian cancer in the presence of either BRCA 1 or BRCA 2 mutation ranges from 16% to 60%. For patients with HNPCC syndrome, the lifetime risk of ovarian cancer is 9% to 12%.
Epithelial cancer accounts for about 90% of ovarian cancers. Common histologies include serous, mucinous, endometroid, transitiona and clear cell types. Germ cell tumors include dysgerminoma, endodermal sinus tumor, malignant teratoma embryonal carcinoma or primary choriocarcinoma. Stromal tumors include granulose tumor or Sertoli-Leydig tumor.
Upon initial presentation, surgery is used for confirmation and staging the cancer. Stage I disease is confined to one or both ovaries. Stage II involves one or both ovaries with extension to the pelvic viscera. Stage III is associated with implants on the abdominopelvic wall or the serosal surface of the liver or involves small bowel or omentum. Stage IV disease involves distant metastasis. The 5 year survival for stage IA disease and grade 1 or 2 histology is greater than 90%. For high risk stage I disease and stage II disease, 5 year survival is 80%. For patients with stage III disease after optimal debulking, 5 year survival is 20% to 30%. This reduces to be less than 10% for stage III patients with suboptimal debulking and stage IV disease.
Stage I ovarian cancer with favorable prognostic features can be treated with surgery alone. For women with high risk, early stage cancer (Stage I grade 3 or stage II disease), adjuvant chemotherapy with platinum based agents show an 11% improvement in progression free survival and 8% improvement in overall survival. For stage III and IV disease, the current standard of care include maximal attempt at surgical cytoreduction followed by chemotherapy with platinum based agents.
Optimal debulking is an important part in the treatment of cancer in the ovaries. Retrospective data have shown that survival is better for women who receive chemotherapy in the presence of low volume disease. In the setting where optimal surgical cytoreduction cannot be achieved, an alternative approach is for the patient to receive chemotherapy up front. For patients who have a partial response to neoadjuvant chemotherapy, it may be appropriate to attempt surgical removal of macroscopic disease at that time.
As for the standard of care in chemotherapy for advanced ovarian-type cancer, studies have shown that paclitaxel/cisplatin combination is superior to cyclophosphamide/cisplatin combination. Later studies showed that carboplatin/paclitaxel is at least as effective as cisplatin/paclitaxel.
Intraperitoneal chemotherapy is an appealing approach for treating a disease that is largely confined in the peritoneal space. GOG 172 which was a phase III clinical trials demonstrated that this regional approach resulted in superior progression free survival and overall survival when compared with the intravenous approach alone. The disadvantage of this approach includes local toxicity, and requirement for intraperitoneal catheter placement.
Because of the high recurrence rate in patients with advanced ovarian cancer, the issue of whether consolidation chemotherapy may improve time to progression and overall survival was examined in a phase III trial comparing 3 and 12 cycles of taxol. Progression free survival favored the 12 cycle arm. However, overall survival was not different between the two arms. Therefore, the oncologist needs to discuss with the patient and allow them to decide whether the improved progression free survival justifies toxicities including peripheral neuropathy and alopecia.
For many patients with advanced ovarian cancer who have an initial treatment response, disease relapses at a later time. The treatment of patients with recurrent disease or resistant disease needs to be individualized. For people with long treatment free interval, similar drugs many be reused. There are also a number of single agent drugs with activity in ovarian cancer. These include altretamine, bevacizumab, docetaxel, etoposide, gemcitabine, liposomal doxorubicin, paclitaxel, tamoxifen, topotecan and vinorelbine.
Radiation can also play a role in the palliation of some patients with recurrent ovarian cancer. Symptoms such as pain from growing pelvic mass or bone metastasis can be palliated. Very rarely cerebral metastasis can develop which can also be treated with radiation.
The best treatment of ovarian cancer needs a team approach between the primary care physician, gynecological oncology surgeon, medical oncologists and radiation oncologists. As more chemotherapeutic agents become available and as we further understand the biology of epithelial ovarian cancer, we hope to further improve the overall survival and quality of life of our patients.
Wednesday, November 17, 2010
Friday, August 20, 2010
What is mesothelioma peritoneal
Peritoneal Mesothelioma is the name given to the cancer that attacks the lining of the abdomen.This type of cancer is caused by ABESTOS exposure and it affects the linings that protects the contents of the abdomen and which also provides a lubrication to enable the organs to move and work effectively. This disease is sometimes referred to as DIFFUSE PERITONEAL MESOTHELIOMA and this is where the cancer has spread out.Accountable for around 10% of mesothelioma cases, this type of abestos related cancer is the second most common(after PLEURAL MESOTHELIOMA).
There are a number of symptoms for these disease. However like all other types of MESOTHELIOMA, there is a very long latency period and symptom may not become evident for decades after exposure. This means that by the time the symptoms have begun,it is often already too late to offer any real constructive treatment. Further delay may be caused due to the fact that the symptoms are generally non specific and could therefore be attributed to a number of more common ailments.Unless your doctor is aware of the fact that you have been exposed to abestos in the past,he or she is likely to consider other options before even contemplating mesothelioma.It is therefore important to let your doctor know of any exposure to abestos as the case may be.
The symptoms of this disease include pain and weakness,weight loss, nausea, loss of appetite abdominal swelling, bowel obstruction. However depending on the location of the tumor, additional problems can be experienced such as breathing problems and severe pains.
There are a number of symptoms for these disease. However like all other types of MESOTHELIOMA, there is a very long latency period and symptom may not become evident for decades after exposure. This means that by the time the symptoms have begun,it is often already too late to offer any real constructive treatment. Further delay may be caused due to the fact that the symptoms are generally non specific and could therefore be attributed to a number of more common ailments.Unless your doctor is aware of the fact that you have been exposed to abestos in the past,he or she is likely to consider other options before even contemplating mesothelioma.It is therefore important to let your doctor know of any exposure to abestos as the case may be.
The symptoms of this disease include pain and weakness,weight loss, nausea, loss of appetite abdominal swelling, bowel obstruction. However depending on the location of the tumor, additional problems can be experienced such as breathing problems and severe pains.
Thursday, August 12, 2010
Prostate cancer - overall
Mesothelioma treatment
Example of an ultrasound affected by prostate cancer (ultrasound can be used to guide a biopsy). Cancer develops from the tissues of the prostate, a gland in the male reproductive system when cells will mutate to spread so uncontrollably.
These can spread (metastasize is) in migrating from the prostate to other parts of the body (especially bones and lymph nodes).
Prostate cancer occurs regardless of benign prostatic hypertrophy (or prostate adenoma). It is in the vast majority of cases adenocarcinoma.
Prostate cancer can cause pain, difficulty urinating, erectile dysfunction and other symptoms. Treatment is by surgery, radiotherapy, hormone therapy and sometimes chemotherapy, or combination of these methods.
Frequency
The rate of breast cancer varies widely throughout the world. It is less widespread in South Asia and Far East, more common in Europe and even the United States. According to the American Cancer Society, breast cancer is rare among Asians and more prevalent among blacks (high rates may also be influenced by the increased effort detection).
Prostate cancer develops most often in men over fifty years. This is the type of cancer most common in men, where he is responsible for more deaths than any other cancer (except lung cancer). However, many men who develop prostate cancer symptoms do not, do not undergo any therapy and die for other reasons. Many factors of genetic origin, toxicological and diet-related seem involved in the development of this cancer.
We find outbreaks of cancer cells in 30 to 70% of cases in studies performed in autopsies of men 70 to 80 years; prostate cancer remains the most often asymptomatic: the probability of a man 50 years know a diagnosis of prostate cancer is only 10%. In 3% of cases, this cancer will be fatal.
Geography of Prostate Cancer
There are significant differences in the expression of this cancer, which seems more common among the black man, or where the family has a history pathological with this condition. From 1983-2002, while deaths from cancer were generally higher in the Caribbean city, deaths from prostate cancer and stomach were twice as common in the Caribbean in the mainland (while colorectal cancer and lung cancer were three times less frequent). This could be explained by both genetic reasons and food (green tea and / or soybeans or other foods rich in selenium) which appear to protect most Japanese living in Japan (while living in the United States is not).
Causes
They are not known with precision
There is a genetic predisposition and the presence of certain genes seems slightly correlated with the onset of the disease. In particular, a mutation on chromosome 8 might explain the higher incidence of this cancer in black American.
Nutritional causes were discussed with a potentially protective role of lycopene. Similarly, exercise may have a slightly protective effect and tobacco a deleterious effect.
Symptomatology and detection
In most cases, prostate cancer is asymptomatic, ie it is discovered when it does not own event to it. It is most often found:
During blood tests, including investigation of the PSA (specific antigen for prostate, whose predictive value and use, without proven benefit to public health, has recently been called into question). The PSA is a protein normally secreted by prostate cells, but cancer cells secrete 10 times more than a normal cell. This property has raised many hopes in terms of screening. The blood level of PSA can be increased by many other factors (the prostate volume, infections and / or inflammation, the mechanical (digital rectal other)...) or decreased by certain treatments for benign hypertrophy (ministered). The thresholds of significance are therefore difficult to establish. It is recognized, however, rates of PSA between 4 and 10 ng / ml are doubtful, but it is clearly significant beyond. Some authors have proposed to bring the rate to its actual weight of the prostate, or assess the free PSA / total PSA, or the kinetic growth rate over 2 years. Scorer still uncertain for screening, the PSA level is, however, a key indicator for monitoring and treatment of cancers reported.
During a rectal examination, conducted as systematic or because of symptoms related to another illness (especially benign prostatic hypertrophy) incidentally, on parts of resection of the prostate during surgical treatment of prostate adenoma.
When it is symptomatic prostate cancer is most often at an advanced stage. It can lead to: acute retention of urine, hematuria, sexual impotence, impaired general condition pain and / or malfunction or failure of other organs associated with the presence of metastases
Diagnosis
The diagnostic orientation based on two key elements: the digital rectal examination and determination of PSA blood. The abnormality of one or both leaves suspect prostate cancer. It will be confirmed or not, by taking a sample of the prostate (biopsy) for examination under a microscope. Only the positivity of these biopsies permits to plan and begin treatment of this cancer. Once confirmed the diagnosis of prostate cancer, we conduct a bone scan in search of bone metastases and abdomino-pelvic CT or MRI abdomino-pelvic to clarify the extension of the tumor in the prostate and houses of possible pelvic lymph node metastases, retroperitoneal or liver.
Clinique
Clinical examination is the fundamental digital rectal exam.
The most specific induration of the gland. This induration may be nodular, it may also involve an entire lobe or the entire gland palpable. A heterogeneous consistency or asymmetry are much less specific signs, which can also translate a simple adenoma, particularly when the prostate is larger.
Ultrasound trans-rectal biopsies
There is currently no consideration imaging practice that could only detect an outbreak of prostate adenocarcinoma with a sensitivity and specificity satisfactory.
Contrary to popular belief still widespread, and although this review and is still often prescribed endorectal ultrasound alone has no relevance to the positive diagnosis of prostate cancer, under the inconvenience it is likely to cause. It shall, however, when its interest is used to guide prostate biopsies. Other imaging modalities (scan, MRI) have an interest in the balance sheet expansion.
Technique
An endorectal ultrasound probe equipped with a guide needle is inserted into the rectum. Biopsies were performed with needles fitted with a notched mandrel. The mandrel penetrates the first. The needle just cover, and decide to imprison and the fragment of prostate located in the notch. The movement of chuck and the needle are automated by a system of springs and the taking is a few hundredths of a second. The screen of the ultrasound, with a landmark representing the path of the needle, permits, thus firing biopsy very precise.
The number of biopsies, and where they should be, are not well codified and many protocols have been proposed: the aim is to obtain a sample as representative as possible. Currently, it is frequently performed 5 to 6 samples per lobe, or 10 to 12 in total. These numbers may be reduced or increased depending on the size of the prostate, tolerance of the patient, or if a second set of biopsies.
Preparation and conduct
This is a frequently performed as an outpatient, ie without hospitalization, or during hospitalization "for days". A rectal preparation (enemas) is often advocated. Many centers now offer systematic antibiotic (short antibiotic treatment to reduce infectious complications). The concomitant anticoagulation is in principle against inappropriate and that any treatment can be subject to arrest or a temporary modification.
Tolerance
Acceptance of the review is particularly variable from one patient to another. Each biopsy is shooting itself very painful. However, their repetition, and especially the presence and movement of the probe are the main factors of discomfort. The inconvenience of this review may justify the use of local or general anesthesia. Local anesthesia with a gel anesthetic (lidocaine gel) has never demonstrated its effectiveness. Local anesthesia by injection of lidocaine on each side of the prostate (nerves pudendaux) has shown in many studies improved tolerance of the examination, however incomplete, because of its low efficiency discomfort associated with the presence of the probe. Anesthesia "general" Mild equimolar mixture of oxygen and nitrous oxide ( "MEOPA") has recently been evaluated and appears very effective in this indication. It is even more interesting that easy to implement because does not require an anesthetist and seems almost devoid of side effects. General anesthesia "classic" is rarely used, reserved for patients who have suffered greatly during the first of a series of prostate biopsies.
Suites
Any pain disappear in a few tens of minutes. Can occur fairly frequent small bleeding through the anus and in urine for 24 to 72 hours without gravity. Small nets blood may also interfere with sperm for several days, again without any consequences.
Anatomopathologie
Cancer begins peripheral portion of the gland, unlike benign prostatic hypertrophy of interest to the central area, périurétrale.
The diagnosis is focused on the examination of the biopsy or surgical specimen.
The seriousness of evolution is correlated with the microscopic appearance (Gleason score), the level of PSA and the spread of the disease.
Bilan extension
The spread of the disease when the disease must be determined in order to better tailor therapy. Therefore the presence of bone metastases, lung and liver, knowing that bone metastases are most frequent. We must look for lymph node metastases in the pelvis and the retrograde (around the abdominal aorta). it must finally try to clarify the extension of the tumor in the prostate, particularly whether the latter exceeds the prostate capsule or not.
The means of imaging used in routine generally low ability to show (ultrasound scan, MRI) or to precisely locate (scan) the original prostate lesions, owing to the low blood of breast cancer. MRI is the least bad review to determine the local extension.
MRI scanners or new generation (volume) are used to search the achievement of lymph nodes, but only nodes whose size is increased are detected. New products in contrast MRI, so-called "super-para-magnetic" could improve the detection of lymph nodes affected.
The positron emission tomography (PET camera, PET-scan) did not indicate however, because of very little or no hypermetabolism prostate cancer.
a blood test can check the status of kidney and liver functions.
Treatment
The age, overall health of humans as well as the extent of spread, appearance under the microscope and the response of cancer to initial treatment are important to predict the outcome of the disease.
As prostate cancer is a disease of elderly men, many will die for other reasons before the prostate cancer could spread or cause symptoms. This makes the difficult choice of treatment. Decide whether or not we treat localized cancer of the prostate (a tumor confined within the prostate) with intent to heal is that arbitration must be made between the positive and negative expected to point of view of patient survival and quality of life.
The treatment should be discussed on a case by case basis following the extension of cancer, the patient's general condition and related diseases. A simple monitoring may be recommended in the elderly or among holders of a very localized.
Medical treatment
Hormone
There is a correlation between the production of testosterone (male hormone) and the multiplication of cancer cells. A blocking or greatly reducing the production of this hormone can effectively curb the disease. Some drugs are administered as a subcutaneous injection every 3 months. Others are administered orally. Side effects are, however numerous, but rarely serious. The hormone, which was the treatment of advanced forms, or metastatic, saw its indications extended to the treatment of tumors rejected for surgery (because of the size of the tumor, the risk of surgery not complete ,...) and why the rate of relapse after radiotherapy remained important. The overall control of the disease, adding radiotherapy and hormone therapy for 3 years, can improve significantly the number of patients for whom the disease remains undetectable. The pulpectomy (testicular tissue ablation) is no longer used since the 90s.
Chemotherapy
Until the early 2000s, the use of cytotoxic chemotherapy in metastatic prostate cancer, and whose usual treatment hormonotherapy by becoming ineffective (tried in particular on increasing PSA despite repeated androgen suppression) 's has proved a failure. The advent of docetaxel (Taxotere °) amended the therapeutic possibilities, Entr'ouvert by mitoxantrone (Novantrone °) some years earlier. For the first time, a drug used in advanced stages of the disease, managed to improve survival and quality of life of patients. Three controlled studies confirm these results. Others are underway to integrate chemotherapy early in the history of the disease for locally advanced tumors, where organic growth but before the onset of metastases, and why not, immediately after surgery to treat possible micro-metastases.
Surgery
It is based on the prostatectomy, known as radical or total. It involves the removal of the prostate and seminal vesicles and may be preceded by a levy of lymph drainage of the prostate. The surgery can be done through open (surgical incision in the abdomen or at the perineum) or by abdominal Coelioscopy; surgery is reserved for cancer localized to the prostate and offers great chance of cure if the cancer is actually located and slightly or moderately aggressive (aggressiveness estimated by the Gleason score), and may lead to urinary incontinence, most often temporary and erectile dysfunction. Currently, there is no superiority of one technique over another with regard to cancer outcomes and results urinary and sexual function.
Coelioscopy
Coelioscopy prostatectomy was used by an American team which published it abandoned in 1997 after 8 cases as the intervention was difficult. It is the French teams that end 1997 and early 1998 took the torch and showed that this technique was feasible. Gaston de Bordeaux, and VALLANCIEN Guillonneau Paris and developed the technical standardization. VALLANCIEN and his team published the technique by transpéritonéale then through peritoneal under which seems simpler. It is now recognized worldwide. With an experience of almost 3,000 transactions, the surgical team Montsouris Institute in Paris has shown the benefits of prostatectomy Coelioscopy: we must retain the shorter hospital stay (5 days against 8 in average according to statistics PMSI 2004, the post operative pain near zero even lower, the rate of transfusion of about 2 to 3% against an average of 15% for open surgery. The strictures of the suture between the bladder and urethra canal are more rare (1.5%). The resumption of activity is fast after about a week.
Cryoablation
The prostate cancer tissue may be destroyed by local application of a very cold gas. The cryoprobe (most often cooled with liquid nitrogen) is introduced in endourétral until the prostate, the correct position of cryode can be verified by various techniques including endoscopy conducted by a pubic trocard addition, transvésical. A cycle of freezing and thawing will be implemented for a few minutes and repeated if necessary, a probe is placed urétrovésicale end technology and allow the evacuation progressive tissue nécrosés by applying the cold, some practicing Transurethral resection of tissue mortified by cryotherapy to accelerate the process. Another technique involves placing special needles through perineal ultrasound and under control.
More about Prostate Cancer: http://treatmentnews.blogspot.com.
Example of an ultrasound affected by prostate cancer (ultrasound can be used to guide a biopsy). Cancer develops from the tissues of the prostate, a gland in the male reproductive system when cells will mutate to spread so uncontrollably.
These can spread (metastasize is) in migrating from the prostate to other parts of the body (especially bones and lymph nodes).
Prostate cancer occurs regardless of benign prostatic hypertrophy (or prostate adenoma). It is in the vast majority of cases adenocarcinoma.
Prostate cancer can cause pain, difficulty urinating, erectile dysfunction and other symptoms. Treatment is by surgery, radiotherapy, hormone therapy and sometimes chemotherapy, or combination of these methods.
Frequency
The rate of breast cancer varies widely throughout the world. It is less widespread in South Asia and Far East, more common in Europe and even the United States. According to the American Cancer Society, breast cancer is rare among Asians and more prevalent among blacks (high rates may also be influenced by the increased effort detection).
Prostate cancer develops most often in men over fifty years. This is the type of cancer most common in men, where he is responsible for more deaths than any other cancer (except lung cancer). However, many men who develop prostate cancer symptoms do not, do not undergo any therapy and die for other reasons. Many factors of genetic origin, toxicological and diet-related seem involved in the development of this cancer.
We find outbreaks of cancer cells in 30 to 70% of cases in studies performed in autopsies of men 70 to 80 years; prostate cancer remains the most often asymptomatic: the probability of a man 50 years know a diagnosis of prostate cancer is only 10%. In 3% of cases, this cancer will be fatal.
Geography of Prostate Cancer
There are significant differences in the expression of this cancer, which seems more common among the black man, or where the family has a history pathological with this condition. From 1983-2002, while deaths from cancer were generally higher in the Caribbean city, deaths from prostate cancer and stomach were twice as common in the Caribbean in the mainland (while colorectal cancer and lung cancer were three times less frequent). This could be explained by both genetic reasons and food (green tea and / or soybeans or other foods rich in selenium) which appear to protect most Japanese living in Japan (while living in the United States is not).
Causes
They are not known with precision
There is a genetic predisposition and the presence of certain genes seems slightly correlated with the onset of the disease. In particular, a mutation on chromosome 8 might explain the higher incidence of this cancer in black American.
Nutritional causes were discussed with a potentially protective role of lycopene. Similarly, exercise may have a slightly protective effect and tobacco a deleterious effect.
Symptomatology and detection
In most cases, prostate cancer is asymptomatic, ie it is discovered when it does not own event to it. It is most often found:
During blood tests, including investigation of the PSA (specific antigen for prostate, whose predictive value and use, without proven benefit to public health, has recently been called into question). The PSA is a protein normally secreted by prostate cells, but cancer cells secrete 10 times more than a normal cell. This property has raised many hopes in terms of screening. The blood level of PSA can be increased by many other factors (the prostate volume, infections and / or inflammation, the mechanical (digital rectal other)...) or decreased by certain treatments for benign hypertrophy (ministered). The thresholds of significance are therefore difficult to establish. It is recognized, however, rates of PSA between 4 and 10 ng / ml are doubtful, but it is clearly significant beyond. Some authors have proposed to bring the rate to its actual weight of the prostate, or assess the free PSA / total PSA, or the kinetic growth rate over 2 years. Scorer still uncertain for screening, the PSA level is, however, a key indicator for monitoring and treatment of cancers reported.
During a rectal examination, conducted as systematic or because of symptoms related to another illness (especially benign prostatic hypertrophy) incidentally, on parts of resection of the prostate during surgical treatment of prostate adenoma.
When it is symptomatic prostate cancer is most often at an advanced stage. It can lead to: acute retention of urine, hematuria, sexual impotence, impaired general condition pain and / or malfunction or failure of other organs associated with the presence of metastases
Diagnosis
The diagnostic orientation based on two key elements: the digital rectal examination and determination of PSA blood. The abnormality of one or both leaves suspect prostate cancer. It will be confirmed or not, by taking a sample of the prostate (biopsy) for examination under a microscope. Only the positivity of these biopsies permits to plan and begin treatment of this cancer. Once confirmed the diagnosis of prostate cancer, we conduct a bone scan in search of bone metastases and abdomino-pelvic CT or MRI abdomino-pelvic to clarify the extension of the tumor in the prostate and houses of possible pelvic lymph node metastases, retroperitoneal or liver.
Clinique
Clinical examination is the fundamental digital rectal exam.
The most specific induration of the gland. This induration may be nodular, it may also involve an entire lobe or the entire gland palpable. A heterogeneous consistency or asymmetry are much less specific signs, which can also translate a simple adenoma, particularly when the prostate is larger.
Ultrasound trans-rectal biopsies
There is currently no consideration imaging practice that could only detect an outbreak of prostate adenocarcinoma with a sensitivity and specificity satisfactory.
Contrary to popular belief still widespread, and although this review and is still often prescribed endorectal ultrasound alone has no relevance to the positive diagnosis of prostate cancer, under the inconvenience it is likely to cause. It shall, however, when its interest is used to guide prostate biopsies. Other imaging modalities (scan, MRI) have an interest in the balance sheet expansion.
Technique
An endorectal ultrasound probe equipped with a guide needle is inserted into the rectum. Biopsies were performed with needles fitted with a notched mandrel. The mandrel penetrates the first. The needle just cover, and decide to imprison and the fragment of prostate located in the notch. The movement of chuck and the needle are automated by a system of springs and the taking is a few hundredths of a second. The screen of the ultrasound, with a landmark representing the path of the needle, permits, thus firing biopsy very precise.
The number of biopsies, and where they should be, are not well codified and many protocols have been proposed: the aim is to obtain a sample as representative as possible. Currently, it is frequently performed 5 to 6 samples per lobe, or 10 to 12 in total. These numbers may be reduced or increased depending on the size of the prostate, tolerance of the patient, or if a second set of biopsies.
Preparation and conduct
This is a frequently performed as an outpatient, ie without hospitalization, or during hospitalization "for days". A rectal preparation (enemas) is often advocated. Many centers now offer systematic antibiotic (short antibiotic treatment to reduce infectious complications). The concomitant anticoagulation is in principle against inappropriate and that any treatment can be subject to arrest or a temporary modification.
Tolerance
Acceptance of the review is particularly variable from one patient to another. Each biopsy is shooting itself very painful. However, their repetition, and especially the presence and movement of the probe are the main factors of discomfort. The inconvenience of this review may justify the use of local or general anesthesia. Local anesthesia with a gel anesthetic (lidocaine gel) has never demonstrated its effectiveness. Local anesthesia by injection of lidocaine on each side of the prostate (nerves pudendaux) has shown in many studies improved tolerance of the examination, however incomplete, because of its low efficiency discomfort associated with the presence of the probe. Anesthesia "general" Mild equimolar mixture of oxygen and nitrous oxide ( "MEOPA") has recently been evaluated and appears very effective in this indication. It is even more interesting that easy to implement because does not require an anesthetist and seems almost devoid of side effects. General anesthesia "classic" is rarely used, reserved for patients who have suffered greatly during the first of a series of prostate biopsies.
Suites
Any pain disappear in a few tens of minutes. Can occur fairly frequent small bleeding through the anus and in urine for 24 to 72 hours without gravity. Small nets blood may also interfere with sperm for several days, again without any consequences.
Anatomopathologie
Cancer begins peripheral portion of the gland, unlike benign prostatic hypertrophy of interest to the central area, périurétrale.
The diagnosis is focused on the examination of the biopsy or surgical specimen.
The seriousness of evolution is correlated with the microscopic appearance (Gleason score), the level of PSA and the spread of the disease.
Bilan extension
The spread of the disease when the disease must be determined in order to better tailor therapy. Therefore the presence of bone metastases, lung and liver, knowing that bone metastases are most frequent. We must look for lymph node metastases in the pelvis and the retrograde (around the abdominal aorta). it must finally try to clarify the extension of the tumor in the prostate, particularly whether the latter exceeds the prostate capsule or not.
The means of imaging used in routine generally low ability to show (ultrasound scan, MRI) or to precisely locate (scan) the original prostate lesions, owing to the low blood of breast cancer. MRI is the least bad review to determine the local extension.
MRI scanners or new generation (volume) are used to search the achievement of lymph nodes, but only nodes whose size is increased are detected. New products in contrast MRI, so-called "super-para-magnetic" could improve the detection of lymph nodes affected.
The positron emission tomography (PET camera, PET-scan) did not indicate however, because of very little or no hypermetabolism prostate cancer.
a blood test can check the status of kidney and liver functions.
Treatment
The age, overall health of humans as well as the extent of spread, appearance under the microscope and the response of cancer to initial treatment are important to predict the outcome of the disease.
As prostate cancer is a disease of elderly men, many will die for other reasons before the prostate cancer could spread or cause symptoms. This makes the difficult choice of treatment. Decide whether or not we treat localized cancer of the prostate (a tumor confined within the prostate) with intent to heal is that arbitration must be made between the positive and negative expected to point of view of patient survival and quality of life.
The treatment should be discussed on a case by case basis following the extension of cancer, the patient's general condition and related diseases. A simple monitoring may be recommended in the elderly or among holders of a very localized.
Medical treatment
Hormone
There is a correlation between the production of testosterone (male hormone) and the multiplication of cancer cells. A blocking or greatly reducing the production of this hormone can effectively curb the disease. Some drugs are administered as a subcutaneous injection every 3 months. Others are administered orally. Side effects are, however numerous, but rarely serious. The hormone, which was the treatment of advanced forms, or metastatic, saw its indications extended to the treatment of tumors rejected for surgery (because of the size of the tumor, the risk of surgery not complete ,...) and why the rate of relapse after radiotherapy remained important. The overall control of the disease, adding radiotherapy and hormone therapy for 3 years, can improve significantly the number of patients for whom the disease remains undetectable. The pulpectomy (testicular tissue ablation) is no longer used since the 90s.
Chemotherapy
Until the early 2000s, the use of cytotoxic chemotherapy in metastatic prostate cancer, and whose usual treatment hormonotherapy by becoming ineffective (tried in particular on increasing PSA despite repeated androgen suppression) 's has proved a failure. The advent of docetaxel (Taxotere °) amended the therapeutic possibilities, Entr'ouvert by mitoxantrone (Novantrone °) some years earlier. For the first time, a drug used in advanced stages of the disease, managed to improve survival and quality of life of patients. Three controlled studies confirm these results. Others are underway to integrate chemotherapy early in the history of the disease for locally advanced tumors, where organic growth but before the onset of metastases, and why not, immediately after surgery to treat possible micro-metastases.
Surgery
It is based on the prostatectomy, known as radical or total. It involves the removal of the prostate and seminal vesicles and may be preceded by a levy of lymph drainage of the prostate. The surgery can be done through open (surgical incision in the abdomen or at the perineum) or by abdominal Coelioscopy; surgery is reserved for cancer localized to the prostate and offers great chance of cure if the cancer is actually located and slightly or moderately aggressive (aggressiveness estimated by the Gleason score), and may lead to urinary incontinence, most often temporary and erectile dysfunction. Currently, there is no superiority of one technique over another with regard to cancer outcomes and results urinary and sexual function.
Coelioscopy
Coelioscopy prostatectomy was used by an American team which published it abandoned in 1997 after 8 cases as the intervention was difficult. It is the French teams that end 1997 and early 1998 took the torch and showed that this technique was feasible. Gaston de Bordeaux, and VALLANCIEN Guillonneau Paris and developed the technical standardization. VALLANCIEN and his team published the technique by transpéritonéale then through peritoneal under which seems simpler. It is now recognized worldwide. With an experience of almost 3,000 transactions, the surgical team Montsouris Institute in Paris has shown the benefits of prostatectomy Coelioscopy: we must retain the shorter hospital stay (5 days against 8 in average according to statistics PMSI 2004, the post operative pain near zero even lower, the rate of transfusion of about 2 to 3% against an average of 15% for open surgery. The strictures of the suture between the bladder and urethra canal are more rare (1.5%). The resumption of activity is fast after about a week.
Cryoablation
The prostate cancer tissue may be destroyed by local application of a very cold gas. The cryoprobe (most often cooled with liquid nitrogen) is introduced in endourétral until the prostate, the correct position of cryode can be verified by various techniques including endoscopy conducted by a pubic trocard addition, transvésical. A cycle of freezing and thawing will be implemented for a few minutes and repeated if necessary, a probe is placed urétrovésicale end technology and allow the evacuation progressive tissue nécrosés by applying the cold, some practicing Transurethral resection of tissue mortified by cryotherapy to accelerate the process. Another technique involves placing special needles through perineal ultrasound and under control.
More about Prostate Cancer: http://treatmentnews.blogspot.com.
What is mesothelioma peritoneal
Peritoneal Mesothelioma is the name given to the cancer that attacks the lining of the abdomen.This type of cancer is caused by ABESTOS exposure and it affects the linings that protects the contents of the abdomen and which also provides a lubrication to enable the organs to move and work effectively. This disease is sometimes referred to as DIFFUSE PERITONEAL MESOTHELIOMA and this is where the cancer has spread out.Accountable for around 10% of mesothelioma cases, this type of abestos related cancer is the second most common(after PLEURAL MESOTHELIOMA).
There are a number of symptoms for these disease. However like all other types of MESOTHELIOMA, there is a very long latency period and symptom may not become evident for decades after exposure. This means that by the time the symptoms have begun,it is often already too late to offer any real constructive treatment. Further delay may be caused due to the fact that the symptoms are generally non specific and could therefore be attributed to a number of more common ailments.Unless your doctor is aware of the fact that you have been exposed to abestos in the past,he or she is likely to consider other options before even contemplating mesothelioma.It is therefore important to let your doctor know of any exposure to abestos as the case may be.
The symptoms of this disease include pain and weakness,weight loss, nausea, loss of appetite abdominal swelling, bowel obstruction. However depending on the location of the tumor, additional problems can be experienced such as breathing problems and severe pains.
Omoluwabi Oluwaseyi is a peritoneal resource personnel. Want to access hot bits of valuable information about this easily preventable menace of a disease? Good!!!! visit http://perimesoth-magic.blogspot.com
There are a number of symptoms for these disease. However like all other types of MESOTHELIOMA, there is a very long latency period and symptom may not become evident for decades after exposure. This means that by the time the symptoms have begun,it is often already too late to offer any real constructive treatment. Further delay may be caused due to the fact that the symptoms are generally non specific and could therefore be attributed to a number of more common ailments.Unless your doctor is aware of the fact that you have been exposed to abestos in the past,he or she is likely to consider other options before even contemplating mesothelioma.It is therefore important to let your doctor know of any exposure to abestos as the case may be.
The symptoms of this disease include pain and weakness,weight loss, nausea, loss of appetite abdominal swelling, bowel obstruction. However depending on the location of the tumor, additional problems can be experienced such as breathing problems and severe pains.
Omoluwabi Oluwaseyi is a peritoneal resource personnel. Want to access hot bits of valuable information about this easily preventable menace of a disease? Good!!!! visit http://perimesoth-magic.blogspot.com
Mesothelioma treatments
There are several methods of treatment for mesothelioma although none of these have a high success rate. In general, the chances of curing a mesothelioma patient depends on how much the cancer has developed and matured when treated. If tackled aggressively in its early stages, there is a good chance of survival. Due to the difficulty of diagnosing mesothelioma in its early stages, many mesothelioma treatments focus on improving the quality of life for patients.
Before a patient is treated upon, a doctor will decide what the best course of treatment is by considering the patient's age, medical history, general well being and even weight. From here, the doctor will decide which of the three most common treatments are most suited to the patient's condition. These treatments are surgery, chemotherapy and radiation therapy.
Surgery
Surgery comes in two different types. Aggressive surgery is treatment which aims to gain long term control against the cancer and palliative procedures which aims to just relieve the patient of symptoms.
Aggressive surgery involves removing the pleura, the lung, the diaphragm and the pericardium. This procedure is known as extra pleural pneumonectomy. The aim of this is to remove as much of the tumour as possible without harming the patient. However, this is a very risky type of surgery and the chances are high of patient fatality within a month. Due to this, only young, fit individuals are referred to this form of treatment. Palliative procedures involve removing just the pleura in order to control the symptoms of the cancer. This is performed when mesothelioma is in an advanced form and is impossible to cure.
Chemotherapy
This is the most commonly known cure of cancer. Chemotherapy uses drugs to treat mesothelioma although many of these drugs have a poor success rate on patients. Combinations of drugs are often used to improve their effect. Some of these combinations have proved to be effective. Chemotherapy of mesothelioma is being improved regularly as research labs and pharmaceutical companies are discovering new and more effective drugs.
Radiation Therapy
Radiation therapy uses radiation to kill the tumour which mesothelioma creates. However, this procedure is extremely difficult because of where the tumour grows. Due to the closeness of the tumour and many vital internal organs such as the heart and lungs, doctors have to be very careful as to the doses of radiation they use. Lower radiation doses can be used however this lowers its effectiveness.
Dual Therapy
This is often used and is just a combination of surgery, chemotherapy and radiation therapy combined. Surgery removes the majority of the tumour cells while chemotherapy and radiation therapy work on removing the remainder. This is an effective method and also lessens the symptoms of the cancer.
Before a patient is treated upon, a doctor will decide what the best course of treatment is by considering the patient's age, medical history, general well being and even weight. From here, the doctor will decide which of the three most common treatments are most suited to the patient's condition. These treatments are surgery, chemotherapy and radiation therapy.
Surgery
Surgery comes in two different types. Aggressive surgery is treatment which aims to gain long term control against the cancer and palliative procedures which aims to just relieve the patient of symptoms.
Aggressive surgery involves removing the pleura, the lung, the diaphragm and the pericardium. This procedure is known as extra pleural pneumonectomy. The aim of this is to remove as much of the tumour as possible without harming the patient. However, this is a very risky type of surgery and the chances are high of patient fatality within a month. Due to this, only young, fit individuals are referred to this form of treatment. Palliative procedures involve removing just the pleura in order to control the symptoms of the cancer. This is performed when mesothelioma is in an advanced form and is impossible to cure.
Chemotherapy
This is the most commonly known cure of cancer. Chemotherapy uses drugs to treat mesothelioma although many of these drugs have a poor success rate on patients. Combinations of drugs are often used to improve their effect. Some of these combinations have proved to be effective. Chemotherapy of mesothelioma is being improved regularly as research labs and pharmaceutical companies are discovering new and more effective drugs.
Radiation Therapy
Radiation therapy uses radiation to kill the tumour which mesothelioma creates. However, this procedure is extremely difficult because of where the tumour grows. Due to the closeness of the tumour and many vital internal organs such as the heart and lungs, doctors have to be very careful as to the doses of radiation they use. Lower radiation doses can be used however this lowers its effectiveness.
Dual Therapy
This is often used and is just a combination of surgery, chemotherapy and radiation therapy combined. Surgery removes the majority of the tumour cells while chemotherapy and radiation therapy work on removing the remainder. This is an effective method and also lessens the symptoms of the cancer.
Mesothelioma treatments is an aid to the ailment safely
Description of mesothelioma
Mesothelioma is mainly caused due to contact with asbestos, which has zeolite. When inhaled, the asbestos fibers reach the pleural layer of our lungs and damages the mesothelial cells. When consumed, the asbestos fibers get to our abdominal cavity and cause peritoneal mesothelioma that can spread to the other parts of the body.
However, it takes the disease 20 to 50 years to attain a full shape and by then the average life of that person shrinks.
Mesothelioma treatments
The determining factors that needs to be taken into account before the commencement of the mesothelioma treatment are:
- The site of the cancer
- The stage of the disease
- The patient's physical condition
The usual types of treatment for mesothelioma are surgery, radiation therapy and chemotherapy. However, often a combination of these treatments is also used.
The primary steps
As the symptoms do not surface during the incubation period of the disease, it is a hindrance to the medical peoples in their diagnosis. The tests, prior to surgery, that are done regarding mesothelioma treatment are:
- Blood test to check the level of blood cells
- A CT or MRI scan to see the area the cancer had extended
- A lungs test to calculate the pumping power of the lungs
- A lung's perfusion test to check the flow of blood to the lungs
- An Echocardiogram to see if the cancer had reached the heart
Surgery
A good doctor-patient relationship really helps the patient to remove the fear of operation, which is to be undergone with an empty stomach, followed by TED stockings and a good anesthesia.
An intravenous infusion, a drainage tube, an oxygen mask and few similar devices form the postoperative mesothelioma treatment.
A chest drain tube helps the damaged lungs to pump in air after the removal of pleura. Pain that starts due to the healing of the damaged nerve cells is somewhat subdued via painkillers.
To end with, breathing and chest exercises come under mesothelioma treatment that accelerate the recovery.
Chemotherapy as mesothelioma treatment
It involves a variety of medications that are used to kill the cancerous cells. Chemotherapy is often administered along with radiation therapy and is considered an effective mesothelioma treatment.
Side effects of Chemotherapy
The side effects of chemotherapy are the decrease in red and white blood cells and platelets leading to anemia, loss of immunity, nausea. Bone marrow along with the cells of stomach, hair, skin and mouth suffer from chemotherapy. However, drugs called growth factors are prescribed that aids to get rid of the above side effects to a great extent.
Radiation therapy
Radiation therapy, the emitting of high-energy rays to damage the DNA of the cancerous cells, both externally and internally, is a practical mesothelioma treatment relieving the patients from this fretfully fatal disease. It can be applied to reduce the tumor before operating and can even go along Chemotherapy.
The radiating rays destroy the damaged cells along with normal cells; but radiation therapy offers more than it takes.
However, you should seek the guidance of radiation oncologist who has a better understanding of the therapeutic process. It is costly and at the same time a powerful mesothelioma treatment.
New age ushers new kinds of mesothelioma treatments
The National Cancer Institute (NCI) via various clinical tests and trials are trying to achieve a better solution that reflects new lights regarding mesothelioma treatments.
- Gene therapy involves the replacement of the living cells of the patient's body by injecting a customized gene that fights the disease by providing a fresh supply of cells.
- Immunotherapy is the process of exciting your own immune system so that it fight backs the disease from the inside.
- Photodynamic Therapy unites a photosensitizing means with a light source reacting with oxygen, releasing certain chemicals to obliterate the melanoma cells.
Remember that mesothelioma treatment can show the frustrated and lonely man a new vista of existence. All types of cancer mesothelioma are life threatening and about 2000 Americans are diagnosed with it each year.
If you are reading this and you have a history of asbestos exposure, the next thing is to get an appointment with a medical practitioner.
Mesothelioma is mainly caused due to contact with asbestos, which has zeolite. When inhaled, the asbestos fibers reach the pleural layer of our lungs and damages the mesothelial cells. When consumed, the asbestos fibers get to our abdominal cavity and cause peritoneal mesothelioma that can spread to the other parts of the body.
However, it takes the disease 20 to 50 years to attain a full shape and by then the average life of that person shrinks.
Mesothelioma treatments
The determining factors that needs to be taken into account before the commencement of the mesothelioma treatment are:
- The site of the cancer
- The stage of the disease
- The patient's physical condition
The usual types of treatment for mesothelioma are surgery, radiation therapy and chemotherapy. However, often a combination of these treatments is also used.
The primary steps
As the symptoms do not surface during the incubation period of the disease, it is a hindrance to the medical peoples in their diagnosis. The tests, prior to surgery, that are done regarding mesothelioma treatment are:
- Blood test to check the level of blood cells
- A CT or MRI scan to see the area the cancer had extended
- A lungs test to calculate the pumping power of the lungs
- A lung's perfusion test to check the flow of blood to the lungs
- An Echocardiogram to see if the cancer had reached the heart
Surgery
A good doctor-patient relationship really helps the patient to remove the fear of operation, which is to be undergone with an empty stomach, followed by TED stockings and a good anesthesia.
An intravenous infusion, a drainage tube, an oxygen mask and few similar devices form the postoperative mesothelioma treatment.
A chest drain tube helps the damaged lungs to pump in air after the removal of pleura. Pain that starts due to the healing of the damaged nerve cells is somewhat subdued via painkillers.
To end with, breathing and chest exercises come under mesothelioma treatment that accelerate the recovery.
Chemotherapy as mesothelioma treatment
It involves a variety of medications that are used to kill the cancerous cells. Chemotherapy is often administered along with radiation therapy and is considered an effective mesothelioma treatment.
Side effects of Chemotherapy
The side effects of chemotherapy are the decrease in red and white blood cells and platelets leading to anemia, loss of immunity, nausea. Bone marrow along with the cells of stomach, hair, skin and mouth suffer from chemotherapy. However, drugs called growth factors are prescribed that aids to get rid of the above side effects to a great extent.
Radiation therapy
Radiation therapy, the emitting of high-energy rays to damage the DNA of the cancerous cells, both externally and internally, is a practical mesothelioma treatment relieving the patients from this fretfully fatal disease. It can be applied to reduce the tumor before operating and can even go along Chemotherapy.
The radiating rays destroy the damaged cells along with normal cells; but radiation therapy offers more than it takes.
However, you should seek the guidance of radiation oncologist who has a better understanding of the therapeutic process. It is costly and at the same time a powerful mesothelioma treatment.
New age ushers new kinds of mesothelioma treatments
The National Cancer Institute (NCI) via various clinical tests and trials are trying to achieve a better solution that reflects new lights regarding mesothelioma treatments.
- Gene therapy involves the replacement of the living cells of the patient's body by injecting a customized gene that fights the disease by providing a fresh supply of cells.
- Immunotherapy is the process of exciting your own immune system so that it fight backs the disease from the inside.
- Photodynamic Therapy unites a photosensitizing means with a light source reacting with oxygen, releasing certain chemicals to obliterate the melanoma cells.
Remember that mesothelioma treatment can show the frustrated and lonely man a new vista of existence. All types of cancer mesothelioma are life threatening and about 2000 Americans are diagnosed with it each year.
If you are reading this and you have a history of asbestos exposure, the next thing is to get an appointment with a medical practitioner.
Mesothelioma treatment stages
Mesothelioma is the term used for a cancerous tumor, which involves the mesothelioma cells of lungs, heart or abdominal organs. Medical specialists in mesothelioma provide treatment to the patients after assessing the stage of the mesothelioma in their specific case. They analyze the location of the cancer, the level to which it is spread and the patient?s age and general health condition.
Malignant mesothelioma is a disease in which the malignant cells are found in the sac that lines the chest or abdomen. There are four stages of malignant mesothelioma. The first stage is localized mesothelioma and the remaining three are considered advanced stages of mesothelioma treatments. Localized mesothelioma is the phase wherein the cancer is discovered in the lung, diaphragm or in the lining of the chest cavity. The patients in their first stage of mesothelioma get their cancer surgically removed by pleurectomy or decortication or extrapleural pneumonectomy.
In the second stage, the cancer is detected to have spread beyond the lining of the chest cavity. In the third stage, the tumor growth spreads into several areas that include chest wall, center of the chest, heart, and throughout the diaphragm. The treatment in the second, third and fourth stages of mesothelium are done in tandem with supportive care. The treatment for these advanced stages focuses on providing a patient with relief from symptoms, as total cure is generally not achieved. The treatment methodology includes thoracentesis that removes fluid accumulation in the chest cavity, operations to remove the tumor and radiation therapy or chemotherapy aimed at easing symptoms.
In the fourth stage, the cancer is in the process of distant metastasis, which implies that it has spread to other organs and tissues far from its site of origin in the pleural, peritoneal, or pericardial mesothelium. Patients suffering from the fourth stage should enroll themselves in clinical trials that evaluate the newest treatment possibilities in large medical centers. Pain management is an essential aspect of the care of such patients. It is important for patients to know that medications are available to effectively treat pain due to mesothelioma. They should request pain medications or discuss pain control problems with their cancer care team.
Mesothelioma Treatments provides detailed information on Mesothelioma Treatment, Mesothelioma Treatment Options, Alternative Mesothelioma Treatment, New Mesothelioma Treatment and more.
Malignant mesothelioma is a disease in which the malignant cells are found in the sac that lines the chest or abdomen. There are four stages of malignant mesothelioma. The first stage is localized mesothelioma and the remaining three are considered advanced stages of mesothelioma treatments. Localized mesothelioma is the phase wherein the cancer is discovered in the lung, diaphragm or in the lining of the chest cavity. The patients in their first stage of mesothelioma get their cancer surgically removed by pleurectomy or decortication or extrapleural pneumonectomy.
In the second stage, the cancer is detected to have spread beyond the lining of the chest cavity. In the third stage, the tumor growth spreads into several areas that include chest wall, center of the chest, heart, and throughout the diaphragm. The treatment in the second, third and fourth stages of mesothelium are done in tandem with supportive care. The treatment for these advanced stages focuses on providing a patient with relief from symptoms, as total cure is generally not achieved. The treatment methodology includes thoracentesis that removes fluid accumulation in the chest cavity, operations to remove the tumor and radiation therapy or chemotherapy aimed at easing symptoms.
In the fourth stage, the cancer is in the process of distant metastasis, which implies that it has spread to other organs and tissues far from its site of origin in the pleural, peritoneal, or pericardial mesothelium. Patients suffering from the fourth stage should enroll themselves in clinical trials that evaluate the newest treatment possibilities in large medical centers. Pain management is an essential aspect of the care of such patients. It is important for patients to know that medications are available to effectively treat pain due to mesothelioma. They should request pain medications or discuss pain control problems with their cancer care team.
Mesothelioma Treatments provides detailed information on Mesothelioma Treatment, Mesothelioma Treatment Options, Alternative Mesothelioma Treatment, New Mesothelioma Treatment and more.
Subscribe to:
Posts (Atom)
